Clinical Trials Directory

Trials / Completed

CompletedNCT00431548

Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)

Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV).

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (planned)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers

Summary

Ocular lesions, including cotton wool spots and retinal hemorrhage, are a common feature of HIV infection and acquired immunodeficiency syndrome (AIDS). The aetiology of these apparently vasoocclusive phenomena in HIV related retinopathy is not well understood. Several hypotheses including infectious damage of the retinal vasculature and altered retinal hemodynamics have been postulated. The latter would be compatible with the theory that the retina of HIV patients is hypoxic. However, direct measurement of oxygen tension in the retina is not possible and indirect methods have to be employed. The study objective was to investigate the reactivity in retinal blood flow to 100% oxygen breathing in patients with HIV.

Conditions

Interventions

TypeNameDescription
DRUG100% O2

Timeline

First posted
2007-02-06
Last updated
2007-02-06

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00431548. Inclusion in this directory is not an endorsement.